Table 3.
Details of Clavien complications for diabetic and control patients
| Controls (n=97) | Diabetics (n=111) | |
|---|---|---|
| No complications | 81 (83.5%) | 79 (71.2%) |
| Clavien I | 9 | 25 |
| Urinary retention | 8 | 19 |
| Ileus | 1 | 1 |
| Basal atelectasis | 1 | |
| Wound dehiscence (managed conservatively) | 1 | |
| Prolonged wound discharge | 1 | |
| Neurapraxia | 1 | |
| Constipation | 1 | |
| Clavien II | 4 | 4 |
| Atrial fibrillation (requiring bisoprolol) | 1 | |
| Pneumonia | 1 | 1 |
| Urinary tract infection | 1 | 1 |
| Blood transfusion | 1 | |
| Wound infection | 2 | |
| Clavien IIIa | 0 | 1 |
| Myocardial infarction, coronary artery stent | 1 | |
| Clavien IIIb | 2 | 2 |
| Washout of deep wound infection | 2 | |
| Evacuation of haematoma | 1 | |
| Reoperation due to malplacement of pedicle screw | 1 | |
| Total complications | 15 (15.5%) | 32 (28.8%) |